1. Modulation of SRSF2 expression reverses the exhaustion of TILs via the epigenetic regulation of immune checkpoint molecules
    Ziqiang Wang et al, 2020, Cellular and Molecular Life Sciences CrossRef
  2. Regulation of alternative splicing of CD44 in cancer
    Lubomir Prochazka et al, 2014, Cellular Signalling CrossRef
  3. SR proteins regulate V6exon splicing of CD44 pre-mRNA
    Tiing Jen Loh et al, 2016, BMB Reports CrossRef
  4. PKC-Theta is a Novel SC35 Splicing Factor Regulator in Response to T Cell Activation
    Robert Duncan McCuaig et al, 2015, Frontiers in Immunology CrossRef
  5. Opposite Roles of Tra2β and SRSF9 in the v10 Exon Splicing of CD44
    Jagyeong Oh et al, 2020, Cancers CrossRef
  6. hnRNP L inhibits CD44 V10 exon splicing through interacting with its upstream intron
    Tiing Jen Loh et al, 2015, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms CrossRef
  7. NSrp70 suppresses metastasis in triple-negative breast cancer by modulating Numb/TβR1/EMT axis
    Yang Zhao et al, 2022, Oncogene CrossRef
  8. Full spectrum of clonal haematopoiesis‐driver mutations in chronic heart failure and their associations with mortality
    Katharina C. Kiefer et al, 2021, ESC Heart Failure CrossRef
  9. The RNA-binding proteins CELF1 and ELAVL1 cooperatively control the alternative splicing of CD44
    Géraldine David et al, 2022, Biochemical and Biophysical Research Communications CrossRef
  10. Potential Gene Interactions in the Cell Cycles of Gametes, Zygotes, Embryonic Stem Cells and the Development of Cancer
    Gregor Prindull, 2015, Frontiers in Oncology CrossRef
  11. Role of CD44 isoforms in epithelial-mesenchymal plasticity and metastasis
    Mark Primeaux et al, 2022, Clinical & Experimental Metastasis CrossRef
  12. Nuclear Speckle-related Protein 70 Binds to Serine/Arginine-rich Splicing Factors 1 and 2 via an Arginine/Serine-like Region and Counteracts Their Alternative Splicing Activity
    Chang-Hyun Kim et al, 2016, Journal of Biological Chemistry CrossRef
  13. Alternative‐splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics
    Laura M. Urbanski et al, 2018, WIREs RNA CrossRef
  14. Splicing factors: Insights into their regulatory network in alternative splicing in cancer
    Jun-Xian Du et al, 2021, Cancer Letters CrossRef